| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute on Aging (NIA) |
| Information provided by: | National Institute on Aging (NIA) |
| ClinicalTrials.gov Identifier: | NCT00000178 |
Purpose
This is a randomized placebo controlled, double blind study. Patients who meet eligibility criteria and decide to participate in the study will be randomly assigned to receive either drug treatment or a placebo. Neither the patients nor the participating investigators will know who is receiving the drugs and who is receiving the placebo. Participation involves 15 outpatient clinic visits over a 68 week period. Patients take study medication at varying doses (the maximum dose is 20 mg daily), along with calcium and vitamin supplements.
| Condition | Intervention | Phase |
|
Alzheimer Disease |
Drug: Prednisone |
Phase III |
| Genetics Home Reference related topics: | Alzheimer disease |
| MedlinePlus related topics: | Alzheimer's Disease |
| ChemIDplus related topics: | Prednisone |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study |
| Official Title: | Multicenter Trial of Prednisone in Alzheimer's Disease |
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Alabama | |||||
| University of Alabama, Birmingham | |||||
| Birmingham, Alabama, United States, 35294-0017 | |||||
| United States, California | |||||
| University of Southern California | |||||
| Los Angeles, California, United States, 90033 | |||||
| University of California, San Diego | |||||
| San Diego, California, United States, 92093-0949 | |||||
| United States, Florida | |||||
| Mayo Clinic Jacksonville | |||||
| Jacksonville, Florida, United States, 32225 | |||||
| University of Miami | |||||
| Miami, Florida, United States, 33140 | |||||
| University of South Florida | |||||
| Tampa, Florida, United States, 33162 | |||||
| United States, Indiana | |||||
| Indiana University Alzheimer's Center | |||||
| Indianapolis, Indiana, United States, 46202 | |||||
| United States, Kansas | |||||
| University of Kansas Medical Center | |||||
| Kansas City, Kansas, United States, 66160 | |||||
| United States, Maryland | |||||
| Johns Hopkins University | |||||
| Baltimore, Maryland, United States, 21224 | |||||
| United States, Minnesota | |||||
| University of Minnesota | |||||
| Minneapolis, Minnesota, United States, 55455 | |||||
| United States, Missouri | |||||
| Washington University | |||||
| St. Louis, Missouri, United States, 63110 | |||||
| United States, New York | |||||
| Mount Sinai Medical Center | |||||
| New York, New York, United States, 10029 | |||||
| Columbia Presbyterian Medical Center | |||||
| New York, New York, United States, 11032 | |||||
| New York University Medical Center | |||||
| New York, New York, United States, 10016 | |||||
| University of Rochester | |||||
| Rochester, New York, United States, 14620 | |||||
| Burke Medical Research Institute | |||||
| White Plains, New York, United States, 10605 | |||||
| United States, Pennsylvania | |||||
| University of Pittsburgh | |||||
| Pittsburgh, Pennsylvania, United States, 15213 | |||||
| United States, Tennessee | |||||
| Vanderbilt University Medical Center | |||||
| Nashville, Tennessee, United States, 37212-8646 | |||||
| United States, Texas | |||||
| University of Texas | |||||
| Dallas, Texas, United States, 75235-9070 | |||||
| Principal Investigator: | Leon Thal, MD. | University of California, San Diego |
More Information
The Alzheimer's Disease Education and Referral (ADEAR) Center is a service of the National Institute on Aging (NIA).
|
| Study ID Numbers: | IA0002, 3U01AG10483-08S2 |
| First Received: | October 29, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000178 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
